Significant alterations in the structure and cellular composition of the distal lung are a defining characteristic of ...

Affinity Technologies today announced strategic actions to cut $4 million in annual costs at its subsidiary CAP/CLIA pathology laboratory.

At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health ...

Proscia sells digital pathology software and artificial intelligence tools to pharmaceutical companies and diagnostic ...

Researchers have uncovered changes in the cellular response throughout lung damage caused by SARS-CoV-2—the virus behind ...

The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.

The abnormal accumulation of extravascular fluid, pulmonary edema settles in the lung interstitium and alveoli. There, it ...

Changes in the cellular response during lung damage caused by Covid-19 have been uncovered by a team of scientists.

One of San Antonio’s promising early-stage biotech companies is making tactical changes to improve its financial performance ...

A recent analysis shows that additional invasive staging modalities lead to relevant changes in target volume in some ...